Long-term Active Surveillance Study for Oral Contraceptives (LASS)

CompletedOBSERVATIONAL
Enrollment

58,303

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

March 31, 2011

Study Completion Date

December 31, 2011

Conditions
Arterial ThromboembolismVenous ThromboembolismBreast Cancer
Trial Locations (1)

Unknown

Center for Epidemiology and Health Research, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT00676065 - Long-term Active Surveillance Study for Oral Contraceptives (LASS) | Biotech Hunter | Biotech Hunter